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The assembly of respiratory syncytial virus (RSV) in lipid-rafts was examined in Hep2 cells. Confocal and electron microscopy showed
that during RSV assembly, the cellular distribution of the complement regulatory proteins, decay accelerating factor (CD55) and CD59,
changes and high levels of these cellular proteins are incorporated into mature virus filaments. The detergent-solubility properties of CD55,
CD59, and the RSV fusion (F) protein were found to be consistent with each protein being located predominantly within lipid-raft structures.
The levels of these proteins in cell-released virus were examined by immunoelectronmicroscopy and found to account for between 5% and
15% of the virus attachment (G) glycoprotein levels. Collectively, our findings suggest that an intimate association exists between RSV and
lipid-raft membranes and that significant levels of these host-derived raft proteins, such as those regulating complement activation, are
subsequently incorporated into the envelope of mature virus particles.
D 2004 Elsevier Inc. All rights reserved.
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Respiratory syncytial virus (RSV) is the major cause of
severe lower respiratory tract disease in several high-risk
groups which include young children, the elderly, and
immunocompromised adults. The mature and infectious
RSV particle comprises a ribonucleoprotein (RNP) core that
is surrounded by a viral envelope in which three different
glycoproteins, the attachment (G), fusion (F), and small
hydrophobic (SH) proteins, are located. Although the
structural organization of the mature RSV particle is well
characterized (Arslanagic et al., 1996; Bachi and Howe,
1973; Brown et al., 2002a; Norrby et al., 1970; Parry et al.,0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.06.038
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E-mail address: r.sugrue@vir.gla.ac.uk (R.J. Sugrue).1979; Roberts et al., 1995), the cellular processes that lead
to assembly of the mature virus are still poorly understood.
Several host-cell factors have been implicated in the
assembly process (Brown et al., 2002a, 2002b; Burke et
al., 1998; Ulloa et al., 1998) and furthermore, the involve-
ment of lipid-raft microdomains in the assembly of RSV, as
well as in several other paramyxoviruses, has been
demonstrated (Ali and Nayak, 2000; Brown et al., 2002b;
Henderson et al., 2002; Jeffree et al., 2003; Manie et al.,
2000; McCurdy and Graham, 2003; Vincent et al., 2000). It
is clear, therefore, that an interaction occurs between the
virus and specific host-cell factors during the assembly
process.
We have shown previously that in Vero cells, RSV
assembly occurs in regions of the cell membrane which are
characterized by the presence of caveolin and the sphingo-
lipid, GM1 (Brown et al., 2002a, 2002b; Jeffree et al.,04) 175–185
G. Brown et al. / Virology 327 (2004) 175–1851762003). These components are associated with specialized
lipid-raft structures that have caveolae-like properties
(Anderson, 1998; Fra et al., 1995; Kurzchalia et al., 1992;
Parton, 1994; Rothberg et al., 1992). Although several
enzyme activities are known to reside within caveolae
(Razani et al., 2002), recent evidence has suggested that
GPI-anchored proteins, such as CD55, are not normally
present within caveolae but are enriched within other non-
caveolae-like lipid-raft structures (Brown and London,
2000; Friedrichson and Kurzchalia, 1998; Fujimoto, 1996;
Mayor et al., 1994; Schnitzer et al., 1995). The complement
cascade is an important process in the host’s defence against
viral infection; however, this process must be controlled to
prevent damage to the host and in this respect, CD55
functions by negatively regulating the complement cascade.
The work presented here shows that RSV associates with
lipid-raft membranes containing CD55 and CD59 and these
negative regulators of the complement pathway are incor-
porated into the envelope of mature RSV particles. This is
the first report to demonstrate the assimilation, into the
envelope of mature RSV particles, of host-factors that have
the potential to regulate the host response to viral infection.Results and discussion
RSVassembles at regions on the surface of Hep2 cells which
are enriched in the complement regulatory proteins CD55
and CD59
CD55 was detected using the polyclonal antibody
CD55P and CD59 was detected using both a polyclonal,
CD59P, or on occasions a monoclonal antibody, CD59M.
The specificity of the polyclonal antibodies in Hep2 cells
was confirmed by Western blotting (Figs. 1A and B). Mock-
infected refers to the exposure of cells to a mock-inoculum
(see Materials and methods). In mock- and virus-infected
Hep2 cells, no significant difference was observed in either
the CD55 or CD59 protein profile. CD55 migrated as a
single 75kDa protein species (CD55/75 k), while CD59
migrated as three closely spaced protein species between 16
and 18kDa. Identical results were obtained using either
CD59P or CD59M (data not shown). In contrast, a similar
analysis in Vero cells (Fig. 1C) revealed a size difference in
CD55 between mock- and virus-infected cells, the signifi-
cance of which is discussed below.
Confocal microscopy was used to examine the distribu-
tion of CD55 and CD59 on the surface of mock- and virus-
infected Hep2 cells (Figs. 2A and B). In mock-infected cells
double-labeled with CD55P and CD59M, both proteins
showed a strong co-localization. In addition, a staining
pattern was observed that was slightly filamentous in
appearance (Fig. 2A). In virus-infected cells, it was noted
that CD55 and CD59 showed a much more pronounced
filamentous staining pattern (Fig. 2B, highlighted by white
arrows), which was similar to that expected for mature RSVfilaments, and both proteins co-localized within these
filamentous structures. The distribution of CD55 and CD59
within mature RSV filaments in infected cells was examined
in cells which were double-labeled with MAb19, an antibody
which recognizes the F protein (Taylor et al., 1992), and
either CD55P (Fig. 2C) or CD59P (Fig. 2D), respectively.
The appearance of mature filaments stained withMAb19 was
clearly visible and furthermore, this analysis showed a high
degree of co-localization between the F protein and both
CD55 and CD59 within these virus structures (yellow
staining pattern in the merged image). The presence of
CD55 within the filaments is most clearly visualized in an
image taken from a Z-stack gallery of images in which a
single cell, double-labeled with CD55P and MAb19, is
viewed in the Y axis , that is, in cross-section (Fig. 2E). In this
image, both the outline of the cell surface and the RSV
filaments are visible and the presence of CD55 within the
filaments can be seen (indicated by yellow staining).
Although confocal microscopy showed the presence of
CD55 and CD59 within virus filaments in Hep2 cells, no
increase in the levels of these proteins in virus-infected cells
had been observed when analyzed by Western blotting
(Figs. 1A and B). This suggests that although virus infection
does not alter expression levels of these proteins, their
distribution changes in a manner similar to that previously
reported for caveolin-1 in Vero cells (Brown et al., 2002a).
This change in distribution is a consequence of RSV
assembly and the subsequent incorporation of these proteins
into the virus envelope.
A more detailed analysis of the surface of virus-infected
cells can be achieved using field emission scanning electron
microscopy (FE SEM). This technique allows visualization
of the mature virus filaments and the distribution of specific
antigens on the cell surface. FE SEM has recently been used
to analyze the distribution of the G protein in the envelope
of mature RSV filaments (Jeffree et al., 2003). The
microscope used contains both a secondary electron (SE)
detector, which allows surface morphology to be visualized,
and a backscatter electron (BSE) detector, which allows the
distribution of immunological markers, such as colloidal
gold, to be visualized. In this report, FE SEM was used to
analyze the distribution of the CD55 protein in mock- and
RSV-infected cells (Figs. 3A–E).
Analysis of the surface of mock- and virus-infected cells
by SEM at low magnification (Figs. 3A and B) shows
morphological changes which occur during virus infection.
Microvilli-like projections are present on the surface of Hep2
cells in the absence of virus. However, following infection,
many filamentous projections can be seen, which are
morphologically similar to the RSV filaments previously
observed (Jeffree et al., 2003; Parry et al., 1979; Roberts et
al., 1995). Microvilli, which are characterized by the
presence of the protein ezrin (Berryman et al., 1995;
Bretscher, 1983) were visualized by confocal microscopy
using mock- and virus-infected cells that had been stained
with an ezrin antibody (Figs. 4A and B). In mock-infected
Fig. 1. Specificity of CD55P and CD59P in mock- (M) and RSV-infected (I) cells. Hep2 cells were incubated for 20 h at 33 8C and examined by Western blot
analysis using (A) CD55P or (B) CD59P. (C) Vero cells were examined by Western blot analysis using CD55P. The respective protein bands are indicated as are
the positions of the molecular mass markers.
G. Brown et al. / Virology 327 (2004) 175–185 177cells, an ezrin staining pattern was visible that was clearly
filamentous in nature and which was consistent with the
microvilli visualized by FE SEM. In contrast, although we
were able to visualize ezrin labeling on virus-infected cells,
the filamentous projections appeared to be smaller. A similar
labeling pattern was observed when mock-and virus-infected
cells were stained using phalloidin-FITC which allowsFig. 2. RSVassembly in Hep2 cells occurs within microdomains that are enriched
20 h at 33 8C and examined by confocal microscopy as described in Materials and m
and (B) RSV-infected cells. Only the merged images are shown. CD55 and CD5
MAb19 (F protein, green) and (C) CD55P (CD55, red) or (D) CD59P (CD59, red
virus-infected cell labeled with MAb19 and CD55P. In all cases, the virus filam
indicated by the yellow staining pattern in the merged image.staining of the F-actin bundles, a major structural component
of microvilli (data not shown). Analysis of virus-infected
cells following labeling with an F protein polyclonal
antibody (anti-F) and anti-ezrin (Fig. 4C) reveals a distinct
staining pattern in each case and that no co-localization of
these antigens occurs, demonstrating that the virus filaments
and the microvilli are separate structures. Collectively, thesein CD55 and CD59. Mock- and RSV-infected Hep2 cells were incubated for
ethods. Cellular distribution of CD55 (green) and CD59 (red) in (A) mock-
9 are present within RSV filaments. RSV-infected cells were labeled with
) and examined by fluorescence microscopy. (E) A cross-section through a
ents are indicated (VF) by white arrows and co-localization of antigens is
Fig. 3. Distribution of CD55 and the G protein within the envelope of RSV filaments. Mock- and RSV-infected cells were processed for FE SEM as described
in Materials and methods. The cells were labeled with CD55P and MAb30 and the presence of bound antibody detected using secondary antibody conjugated
to 20 and 5 nm colloidal gold particles, respectively. The individual images obtained using the secondary electron (SE) and backscatter electron (BSE) detectors
are shown. Comparison of the surface of (A) mock- and (B) RSV-infected cells at low magnification (magnification 20,000). Distribution of CD55 and G
protein on the surface of mock- (C and D) and virus-infected (E and F) cells (magnification 40,000). (G) High magnification image showing infected cells in
which the SE and BSE images are merged into single images (magnification 100,000). The 20 nm and 5 nm colloidal gold particles are visualized as large
and small white spots, respectively. (*) highlights CD55 protein clusters both in the virus filaments (VF) and the microvilli (mv). The presence of the G protein
is highlighted by white arrows.
G. Brown et al. / Virology 327 (2004) 175–185178results suggest that during virus egress, morphological
changes occur on the cell surface which are manifested by
subtle changes in the structure of microvilli. In this regard, it
is interesting to note that changes in the structure of the
cytoskeleton have been reported during RSV infection
(Bitko et al., 2003; Burke et al., 1998).Mock- and virus-infected cells were labeled both with
MAb30, a reagent that recognizes the virus envelope G
protein (Taylor et al., 1992), and CD55P, and the presence of
each bound antibody detected using secondary antibodies
conjugated to 5 and 20 nm gold, respectively. Analysis of the
cell surface by FE SEM at higher magnification allowed the
Fig. 4. Morphological changes occur on the cell surface during virus infection. Mock (A) and virus-infected (B) cells were labeled with anti-ezrin and the cells
viewed by confocal microscopy. (C) Virus-infected cells labeled with anti-F (red) and anti-ezrin (green) and the distribution of each antigen visualized by
confocal microscopy. Only the merged image is shown. The virus filaments (white arrow) and microvilli (mv) are indicated.
G. Brown et al. / Virology 327 (2004) 175–185 179labeling pattern of CD55 in mock- and virus-infected cells to
be compared (Figs. 3C–F). The presence of the microvilli-
like projections on the surface of mock-infected cells was
observed (Fig. 3C) and although CD55 was distributed over
the whole cell surface, an enrichment of the label was visible
on these cellular structures (Fig. 3D, indicated by 20 nm gold
particles). Additionally, in many cases, small clusters of gold
particles, between 3 and 5 particles, were visualized (Fig. 3D,
highlighted by *). Each particle in the 20 nm gold conjugate is
coated with approximately 50 molecules of IgG and thus, in
theory, can bind the same number of primary antibody
molecules (British Biocell International, personal communi-
cation). This suggests therefore, that these gold clusters may
denote the presence of localized concentrations of CD55 on
the cell membrane. As expected, no 5 nm gold particles were
detected, indicating the absence of bound MAb30. In
contrast, in infected cells, an abundance of virus filaments
was visible on the cell-surface (Fig. 3E), which showed
strong labeling with both the 5 and 20 nm gold particles (Fig.
3F). This agrees with the fluorescence microscopy observa-
tions and confirms the presence of both proteins within the
filaments. In some instances, the 20-nm gold particles
appeared to form in small clusters suggesting that localized
concentrations of CD55 may be present within the virus
filaments. This can be seen more clearly in a higher
magnification where the images from the SE and BSE
detectors are superimposed in a single merged image (Fig.
3G, highlighted by *).
RSV assembly occurs in lipid-rafts containing CD55 and
CD59
Lipid-raft membranes were examined in Hep2 cells to
determine the extent to which CD55 and CD59 are in these
structures. Proteins associated with lipid-raft membranes are
soluble in detergents such as NP40 and octyl-h-glucoside
but they are characterized by their resistance to solubiliza-
tion by Triton X-100 at 4 8C (Brown and London, 1998).
The Triton-solubility of the F protein, CD55 and CD59 in
RSV-infected Hep2 cells was examined by flotation gradient
analysis (Fig. 5A).Total membranes prepared from virus-infected cells
were extracted with 1% Triton X-100 and fractionated in
a sucrose step-gradient (35% and 5% sucrose) as described
in Materials and methods. The presence of the F protein
was detected using MAb169 (Rixon et al., 2004) and
specific raft proteins in gradient fractions were detected by
Western blot analysis using relevant antibodies. In the
flotation gradient, although a proportion of the F protein
was in the soluble fraction (Fig. 5A, fraction 11), significant
levels of the F protein and both the CD55 and CD59
proteins were found in the lipid-raft membrane fraction
(Fig. 5A, fraction 3). Furthermore, this fraction also
contained caveolin-1 (cav-1) and flotillin-1 (flot-1) (Fig.
5B), two proteins known to associate with lipid-raft
membrane structures (Bickel et al., 1997; Sargiacomo et
al., 1993). In a similar analysis, transferrin receptor (tfr), a
non-raft marker, was found almost exclusively in the non-
raft fraction of the gradient. In contrast, flotation gradient
analysis of membranes extracted with 1%NP40/60 mM
octyl-h-glucoside under identical conditions showed the F
protein to be located entirely within the soluble fraction
(Fig. 5A) indicating its efficient solubilization by this
detergent combination. Thus the data from microscopy
and flotation gradient analyses indicate that in Hep2 cells,
lipid-raft microdomains containing CD55 and CD59 are
primary sites for RSV assembly.
CD55 is present within the envelope of infectious RSV
particles
The above data provided evidence that CD55 and CD59
were associated with the envelope of RSV during virus
assembly. We therefore wished to determine if these host-
derived proteins were present in the envelope of mature
virus particles. Non-cell-associated RSV (i.e., cell-free virus
in tissue culture medium) loses its predominantly filamen-
tous morphology, becoming more rounded in appearance
(Brown et al., 2002a; Lehmkuhl et al., 1980). Virus particles
were double-labeled with CD55P or CD59P and MAb 30
and examined by negative staining (Fig. 6). The presence of
host-derived proteins and the G protein was detected using
Fig. 5. Flotation gradient analysis of RSV-infected cell membranes. Membranes were prepared from virus-infected cells and examined by flotation gradient
analysis as described in Materials and methods. Specific proteins were located in gradient fractions by Western blot analysis using relevant antibodies. (A)
Distribution of CD55 and CD59 after Triton-extraction and of the F protein (presence of the F1 subunit) under different extraction conditions. 1 is the top
fraction and 11 the bottom fraction. (B) Distribution of the two raft markers, caveolin-1 (cav-1) and flotillin-1 (flot-1) and the non-raft marker transferrin
receptor (tfr) are shown.
G. Brown et al. / Virology 327 (2004) 175–18518010 nm and 5 nm gold probe, respectively. As expected, the
virus particles were labeled efficiently with MAb 30 over
the entire virus particle. In contrast, although labeling of the
virus particles with either CD55P or CD59P was observed,
the labeling pattern of these antibodies appeared to beFig. 6. Immunonegative staining of virus particles in the inoculum. The virus inoc
presence of bound antibody detected using secondary antibody conjugated to 10 nm
samples were then stained as described in Materials and methods (magnification
presence of 10 nm (Y) and 5 nm (*) gold particles are highlighted. Scale bar reconcentrated at specific locations in the virus envelope. A
comparison of the level of labeling of the G protein with that
of either CD55 or CD59 suggested that these host-derived
proteins accounted for approximately 5–15% of the detect-
able gold label on the virus particles.ulum was labeled with MAb30 and either (A) CD55P or (B) CD59 and the
(CD55 or CD59) and 5 nm (G protein) colloidal gold particles. The labeled
40,000). Representative images of labeled virus particles are shown. The
presents 100 nm.
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latory proteins are present in the envelope of virus particles
in the inoculum. It was decided therefore to analyze the
distribution of CD55 in more detail to determine if it was
present in the envelope of mature virus particles during the
initial stages of cell attachment. In this study, Vero cells were
infected with RSV (prepared in Hep2 cells) and the CD55
analyzed using several methods. In mock-infected cells, a
single 55kDa protein species (CD55/55k) was detected by
Western blotting which represents the endogenous CD55
expressed in Vero cells (Fig. 1C). This was clearly
distinguishable from the 75 kDa CD55 species expressed
in Hep2 cells (Fig. 1A), which presumably reflects the cell-
specific differences in O-linked glycosylation described
previously (e.g., Nakagawa et al., 2001). In virus-infected
cells, a level of CD55/55 k similar to that in mock-infected
cells was observed, but a second major CD55 species was
also present which had a mass similar to the CD55 of Hep2
cells. This was not detected in mock-infected Vero cells
suggesting that this second CD55 species represented virus-
associated CD55 present in the input virus.
Mock- and RSV-infected Vero cells were examined
further by labeling with CD55P andMAb19, and the staining
pattern observed using confocal microscopy. In mock-Fig. 7. Distribution of virus antigen and CD55 in RSV-infected Vero cells. (A) Vero
of CD55 (green) and the F protein (red) examined at 20 h PI by fluorescence micr
(red) was examined by fluorescence microscopy during the initial stages of infec
processing for fluorescence microscopy. The cells were labeled with MAb19 (F pr
and in all cases, co-localization of CD55 with the virus antigens is indicated byinfected cells, CD55P exhibited a diffuse staining pattern
throughout the cell (Fig. 7A), suggesting a uniform distribu-
tion of CD55. In virus-infected cells labeled with CD55P, the
appearance of a more intense punctate staining was observed
(Fig. 7A). As expected, staining of infected cells with
MAb19 revealed the presence of mature virus filaments,
but these virus structures did not co-localize with CD55.
Thus, a cell-type specific difference appears to exist in the
biochemical characteristics of the raft structures used during
virus assembly since CD55 cannot be detected in virus
filaments in Vero cells by fluorescence microscopy, whereas
it is evident in the virus filaments that form on Hep2 cells.
In contrast, the punctate CD55 staining pattern observed
in virus-infected cells appeared to show a strong co-
localization with MAb19. We examined the possibility that
this alternative staining pattern represented the initial sites of
contact between the virus envelope and host-cell membrane
following virus attachment, that is, input virus. RSV-
infected cells were examined during the initial phase of
infection (0–4 h PI) using fluorescence microscopy and FE
SEM. This allowed simultaneous visualization of the
distribution of both CD55 and virus particles at the early
stages of infection. Cells were exposed to the virus for
between 0.5 and 4 h after which the cells were extensivelycells were mock-infected or infected with RSVand the cellular distribution
oscopy. (B) The cellular distribution of CD55 (green) and the virus antigens
tion. Cells were exposed to the virus inoculum for either 0.5 or 4 h before
otein) or MAb30 (G protein) and CD55P. Virus filaments are indicated (VF)
the yellow staining pattern (highlighted by white arrows).
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MAb19 or MAb30 (Fig. 7B). Analysis by fluorescence
microscopy revealed co-localization between CD55 and
MAb19 very early in infection, starting within 0.5 h and
increasing up to at least 4 h PI, which is consistent with an
increase in virus attachment over a 4 h time period.
FE SEM was used to analyze the distribution of CD55,
MAb30 and virus particles on the surface of Vero cells,
following a brief exposure to the virus inoculum (Fig. 8).
The presence of spherical particles was observed on the cell
surface which were indistinguishable from the virus
particles in the virus inoculum detected by immunonegative
TEM. These particles ranged in diameter from 200 to 300
nm and were heavily labeled with MAb30, confirming their
viral origin. Vero cells were double-labeled with CD55P and
MAb30 and the presence of each antigen was visualized
using 20 nm (CD55) and 5 nm (G protein) gold probe,
respectively (Fig. 8, inset). At high magnification, the
different sizes of gold probe on the cell-surface were clearly
distinguishable, allowing determination of the distribution
of each antigen. These structures showed a CD55 labeling
pattern similar to that observed on virus particles in the virus
inoculum. Collectively, the results obtained by light (Fig. 7)
and electron microscopy (Figs. 6 and 8) support the
conclusion that high levels of these complement regulatory
proteins are incorporated into the envelope of mature virus
particles and that these proteins are present within the virion
during the initial stages of cell attachment.
This report provides that evidence in Hep2 cells, RSV
associates with lipid-raft membranes that are enriched in theFig. 8. CD55 is present within the envelope of RSV particles during the initial stages
which they were fixed, labeled with MAb30 and prepared for FE SEM as described
particles (5) can be seen at low magnification (magnification 20,000). The pres
Inset, cells were exposed to the virus inoculum for 4 h after which they were fixed
the G protein (5 nm) can be seen at high magnification (magnification 130,000complement regulatory proteins, CD55 and CD59, high
levels of which are subsequently incorporated into the
envelope of maturing virus particles. Incorporation of
CD55 and CD59 is presumably a consequence of their
presence within the lipid-raft structures which are used as
platforms for virus assembly (Briggs et al., 2003) and results
in the formation of a viral envelope that contains both virus-
encoded proteins and an array of host-derived proteins.
Although CD55 and CD59 are present within the virus
envelope, it is unlikely that they represent specific require-
ments for virus assembly. We have observed the formation of
RSV filaments on the surface of infected CHO cells, a cell
line that does not express CD55 (unpublished observations).
However, these cell-derived proteins may impart important
properties to the virus since, for example, CD55, which is
expressed on the surface of many cell types (Miwa and
Song, 2001), inhibits the formation of the C3 and C5
convertases and accelerates the degradation of these
molecules (Fujita et al., 1987), thus negatively regulating
the complement cascade. Viruses have developed different
strategies with which to counter the effects of the comple-
ment system (reviewed in Favoreel et al., 2003) and one such
strategy is the incorporation of cellular complement control
factors. For example, CD55 and CD59 have been shown to
be incorporated into the envelope of several viruses during
virus assembly, including both DNA (e.g., cytomegalovirus,
Spear et al., 1995) and RNA viruses (e.g., HIV, Frank et al.,
1996; Marschang et al., 1995; Schmitz et al., 1995; Stoiber et
al., 1996). However, of the viruses known to incorporate
these host factors into mature virus particles, the role ofof cell attachment. (A) Cells were exposed to the virus inoculum for 4 h after
in Materials and methods. The presence of microvilli (mv) and bound virus
ence of bound gold (10 nm) on the virus particles is visible as white spots.
and labeled with CD55P and MAb30. The distribution of CD55 (20 nm) and
) in these merged images as large and small white spots, respectively.
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(Stoiber et al., 1997). In this case, the presence of virus-
associated CD55 imparts potentially important biological
properties to the mature HIV-1 particles, such as an increased
resistance to complement-mediated lysis (Saifuddin et al.,
1995, 1997; Stoiber et al., 1996). It is possible that the
presence of these proteins within the RSV envelope may
protect the virus in a similar manner. For example, RSV is
one of several respiratory pathogens that cause the middle
ear infection, otitis media, in neonates (Heikkinen, 2001;
Heikkinen and Chonmaitree, 2003), a condition that is
characterized by a strong complement activation (Narkio-
Makela et al., 1999). Thus, the possibility exists that the
presence of CD55 in the virus envelope may protect the virus
from complement inactivation during infection. However, at
present, the biological consequences of the virus-associated
complement proteins remain to be established.Materials and methods
Cells and viruses
The RSVA2 strain was used throughout this study. Hep2
cells were maintained in Dulbecco’s Modified Eagle’s
Medium (DMEM) supplemented with 10% fetal calf serum
(FCS) and antibiotics.
Preparation of mock- and RSV inocula
Hep2 cells were either infected with RSV or left
uninfected (mock-infected) and incubated at 33 8C for 3
days in DMEM supplemented with 2% FCS before
harvesting. The cells, together with tissue culture medium,
were collected and clarified by centrifugation (2000  g for
15 min) to remove the cell debris. The presence of RSV in
the RSV-inoculum and the removal of cell debris from both
the mock- and RSV-inocula was confirmed by TEM.
Antibodies
Antibodies against the RSV F (MAb19) and G (MAb30)
proteins were obtained from Geraldine Taylor (IAH,
Compton, UK). The F protein antibody, MAb169, was
prepared by immunizing mice with bacterially expressed
recombinant HRSV A2 F protein and the F protein
polyclonal antibody was provided by Jose Melero (Instituto
de Salud Carlos III, Madrid, Spain). The CD55 antibody
was provided by Ian Goodfellow and David Evans
(Virology Division, University of Glasgow, UK) and the
CD59 antibodies were obtained from Brad Spiller (Uni-
versity of Cardiff, UK). The caveolin-1 (N20) antibody was
purchased from Santa Cruz Biotechnology, the ezrin and
flotillin antibodies were purchased from BD Transduction
Laboratories and the transferrin receptor antibody was
purchased from Zymed Laboratories.Western blotting
Western blotting was performed as described previously
(Brown et al., 2002a). Briefly, proteins were separated by
SDS PAGE after which they were transferred by Western
blotting on to PVDF membranes. The membranes were
washed, blocked with 1% Marvel, and probed with
specific primary antibodies for 1 h. The membranes were
then washed, probed either with goat anti-mouse or anti-
rabbit IgG (whole molecule) peroxidase conjugate (Sigma)
as appropriate and the protein bands visualized using the
ECL protein detection system (Amersham). Apparent
molecular masses were estimated using Rainbow protein
markers (Amersham) in the molecular weight range 14.3–
220 kDa.
Immunofluorescence
Cells were seeded on 13 mm glass coverslips and either
mock- or RSV-infected and incubated overnight at 33 8C
after which the cells were fixed with 3% paraformalde-
hyde in PBS for 30 min at 4 8C. The fixative was
removed and the cells washed 5 times with PBS + 1 mM
glycine and once with PBS. The fixed cells were
permeabilized with 0.1% saponin/PBS at 25 8C for 15
min. Following incubation at 25 8C for 1 h with the
primary antibody, the cells were washed and incubated for
a further 1 h with the secondary antibody, either goat anti-
mouse or anti-rabbit IgG (whole molecule) conjugated to
either Cy5 or FITC as appropriate (1/100 dilution). The
stained cells were mounted on slides using Citifluor and
visualized with a Zeiss Axioplan 2 confocal microscope.
The images were processed using LSM 510 v2.01
software.
Field emission scanning electron microscopy (FE SEM)
This was performed as described previously (Jeffree et
al., 2003). Cells on glass coverslips were either mock-
infected or infected with RSV and incubated overnight at
33 8C. Cells were fixed with 0.5% glutaraldehyde in PBS
at 4 8C for 30 min. The fixed monolayers were incubated
in PBS supplemented with 2 mM glycine for 20 min and
then washed extensively with PBS. The cells were
incubated at 25 8C for 4 h with MAb30 and CD55P,
washed, and then incubated for a further 4 h either in goat
anti-mouse IgG (whole molecule) conjugated to 5 nm
colloidal gold (Sigma) or goat anti-rabbit IgG (whole
molecule) conjugated to 20 nm colloidal gold (British
Biocell International). The monolayers were washed with
PBS, fixed with 2.5% glutaraldehyde in PBS and
processed for SEM as described previously. The samples
were visualized in a Hitachi 4700 F field emission
scanning electron microscope using appropriate settings
and digital images were recorded using Hitachi FE
PCSEM (ver 3.2) software.
G. Brown et al. / Virology 327 (2004) 175–185184Immunonegative staining
A droplet of the clarified tissue culture medium from
infected cells was placed on a formvar-coated grid and the
virus adsorbed for 10 min. Grids were inverted on to a
droplet of primary antibody for 3 h, washed in PBS, and
then incubated for a further 1.5 h with anti-rabbit IgG
(whole molecule) 10 nm colloidal gold and anti-mouse IgG
(whole molecule) 5 nm colloidal gold conjugates (British
Biocell International). The grids were then washed, stained
with uranyl acetate (saturated in 50:50 ethanol/water) and
counter-stained with lead citrate. Samples were examined
using a Jeol 100S transmission electron microscope.Acknowledgment
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